World’s blackest black? Purdue made the world’s whitest white

In paint form, the world's "whitest white" reflects so much light that surfaces become cooler than the surrounding air.

World’s blackest black? Purdue made the world’s whitest white
Credit: yuravector/Adobe Stock/Big Think
  • Scientists at Purdue University announce the whitest white ever developed. It will be available as paint and a nanofilm.
  • The new paint can actually cool surfaces on which it's applied, potentially reducing the need for climate-unfriendly air conditioners.
  • This is the second whitest white to come from these researchers, and they believe this is about as white as any material could ever be.

A few years ago, researchers announced the development of the blackest black ever, a place where colors go to die. It was called Vantablack®, and it was so absorptive of visible light that only the tiniest amount escaped its surface to reflect back to our eyes. (All of that light energy is dissipated into the surrounding substrate, so Vantablack doesn't become hot.)

In a new paper published in the journal ACS Applied Materials & Interfaces, scientists at Purdue University announced BaSO4 (barium sulfate), the whitest white ever. BaSO4 is practically impervious to the colors of the visible spectrum. Even better, while it's a very cool invention in the colloquial sense, it's also cool in the thermal sense.

The coolest white

The infrared image on the right shows how a square of the super-white paint and the board on which it's painted — shown in a normal image on the left — are cooler than the surrounding materials.Credit: Purdue University/Joseph Peoples


Most outside paints actually warm the surfaces to which they're applied. While there are already some reflective paints on the market, they only reflect 80 to 90 percent of sunlight, not enough for a cooling effect.

By contrast, BaSO4 results in 98.1 percent of sunlight bouncing off. According to senior investigator Xuilin Ruan, "If you were to use this paint to cover a roof area of about 1,000 square feet, we estimate that you could get a cooling power of 10 kilowatts. That's more powerful than the central air conditioners used by most houses."

Ruan and his colleagues tested BaSO4 using thermocouples, high-accuracy devices that measure voltage to determine temperature. They found that at night, BaSO4 surfaces are 19° F. cooler than surrounding air. Under strong sunlight the effect is not quite so extreme, but still dramatic: 8° of cooling.

The researchers even found the paint works in cold weather. Testing it on a 43° F. day, the surface on which BaSO4 was painted was a brisk 25° F. Their tests also indicate that BaSO4 is hardy enough for outdoor conditions.

How the new white was developed

Xuilin Ruan and a square of BaSO4Credit: Purdue University/Jared Pike


Research in the field of radiative paint for cooling goes back to the 1970s, though Ruan's team has been working toward BaSO4 for only six years. Along the way, they analyzed over 100 reflective materials, trying them out in about 50 experimental formulations.

Lead author, postdoc Xiangyu Li explains, "We looked at various commercial products, basically anything that's white. We found that using barium sulfate, you can theoretically make things really, really reflective, which means that they're really, really white."

The whitest white paint before — developed by the same team just last autumn — depended on calcium carbonate, a compound commonly found in seashells, rocks, and blackboard chalk.

The team crammed as many tiny BaSO4 particles into the paint as possible. Says Li: "Although a higher particle concentration is better for making something white, you can't increase the concentration too much. The higher the concentration, the easier it is for the paint to break or peel off."

Another factor that makes the team's BaSO4 formulation so reflective is that the researchers used barium sulfate particles of many different sizes. When it comes to reflecting light, size matters.

Co-author and PhD student Joseph Peoples said, "A high concentration of particles that are also different sizes gives the paint the broadest spectral scattering, which contributes to the highest reflectance."

The team's formulation method, they report, is compatible with commercial paint production.

Cool support for the planet

Purdue has applied for patents relating to BaSO4, though there are as yet no plans to make it commercially available.

However, the sooner they release it, the better. Air conditioning currently accounts for 12% of U.S. energy consumption. Also, many air conditioners use hydrofluorocarbons (HFCs). While HFCs constitute just a small percentage of greenhouse gases, they trap thousands of times the amount of heat as carbon dioxide.

Therefore, BaSO4 can play a role in combating global warming by reducing energy consumption and the emission of HFCs.

U.S. Navy controls inventions that claim to change "fabric of reality"

Inventions with revolutionary potential made by a mysterious aerospace engineer for the U.S. Navy come to light.

U.S. Navy ships

Credit: Getty Images
Surprising Science
  • U.S. Navy holds patents for enigmatic inventions by aerospace engineer Dr. Salvatore Pais.
  • Pais came up with technology that can "engineer" reality, devising an ultrafast craft, a fusion reactor, and more.
  • While mostly theoretical at this point, the inventions could transform energy, space, and military sectors.
Keep reading Show less

Why so gassy? Mysterious methane detected on Saturn’s moon

Scientists do not know what is causing the overabundance of the gas.

An impression of NASA's Cassini spacecraft flying through a water plume on the surface of Saturn's moon Enceladus.

Credit: NASA
Surprising Science
  • A new study looked to understand the source of methane on Saturn's moon Enceladus.
  • The scientists used computer models with data from the Cassini spacecraft.
  • The explanation could lie in alien organisms or non-biological processes.
Keep reading Show less

CRISPR therapy cures first genetic disorder inside the body

It marks a breakthrough in using gene editing to treat diseases.

Credit: National Cancer Institute via Unsplash
Technology & Innovation

This article was originally published by our sister site, Freethink.

For the first time, researchers appear to have effectively treated a genetic disorder by directly injecting a CRISPR therapy into patients' bloodstreams — overcoming one of the biggest hurdles to curing diseases with the gene editing technology.

The therapy appears to be astonishingly effective, editing nearly every cell in the liver to stop a disease-causing mutation.

The challenge: CRISPR gives us the ability to correct genetic mutations, and given that such mutations are responsible for more than 6,000 human diseases, the tech has the potential to dramatically improve human health.

One way to use CRISPR to treat diseases is to remove affected cells from a patient, edit out the mutation in the lab, and place the cells back in the body to replicate — that's how one team functionally cured people with the blood disorder sickle cell anemia, editing and then infusing bone marrow cells.

Bone marrow is a special case, though, and many mutations cause disease in organs that are harder to fix.

Another option is to insert the CRISPR system itself into the body so that it can make edits directly in the affected organs (that's only been attempted once, in an ongoing study in which people had a CRISPR therapy injected into their eyes to treat a rare vision disorder).

Injecting a CRISPR therapy right into the bloodstream has been a problem, though, because the therapy has to find the right cells to edit. An inherited mutation will be in the DNA of every cell of your body, but if it only causes disease in the liver, you don't want your therapy being used up in the pancreas or kidneys.

A new CRISPR therapy: Now, researchers from Intellia Therapeutics and Regeneron Pharmaceuticals have demonstrated for the first time that a CRISPR therapy delivered into the bloodstream can travel to desired tissues to make edits.

We can overcome one of the biggest challenges with applying CRISPR clinically.

—JENNIFER DOUDNA

"This is a major milestone for patients," Jennifer Doudna, co-developer of CRISPR, who wasn't involved in the trial, told NPR.

"While these are early data, they show us that we can overcome one of the biggest challenges with applying CRISPR clinically so far, which is being able to deliver it systemically and get it to the right place," she continued.

What they did: During a phase 1 clinical trial, Intellia researchers injected a CRISPR therapy dubbed NTLA-2001 into the bloodstreams of six people with a rare, potentially fatal genetic disorder called transthyretin amyloidosis.

The livers of people with transthyretin amyloidosis produce a destructive protein, and the CRISPR therapy was designed to target the gene that makes the protein and halt its production. After just one injection of NTLA-2001, the three patients given a higher dose saw their levels of the protein drop by 80% to 96%.

A better option: The CRISPR therapy produced only mild adverse effects and did lower the protein levels, but we don't know yet if the effect will be permanent. It'll also be a few months before we know if the therapy can alleviate the symptoms of transthyretin amyloidosis.

This is a wonderful day for the future of gene-editing as a medicine.

—FYODOR URNOV

If everything goes as hoped, though, NTLA-2001 could one day offer a better treatment option for transthyretin amyloidosis than a currently approved medication, patisiran, which only reduces toxic protein levels by 81% and must be injected regularly.

Looking ahead: Even more exciting than NTLA-2001's potential impact on transthyretin amyloidosis, though, is the knowledge that we may be able to use CRISPR injections to treat other genetic disorders that are difficult to target directly, such as heart or brain diseases.

"This is a wonderful day for the future of gene-editing as a medicine," Fyodor Urnov, a UC Berkeley professor of genetics, who wasn't involved in the trial, told NPR. "We as a species are watching this remarkable new show called: our gene-edited future."

Quantcast